DARA RVD For High Risk SMM

Summary

DARA RVD For High Risk SMM is a clinical trial^[1].

Key Facts

• DARA RVD For High Risk SMM is in the country of United States^[2].
• DARA RVD For High Risk SMM's instance of is recorded as clinical trial^[3].
• DARA RVD For High Risk SMM's start time is recorded as +2021-04-09T00:00:00Z^[4].
• DARA RVD For High Risk SMM's end time is recorded as +2023-02-01T00:00:00Z^[5].
• DARA RVD For High Risk SMM's main subject is recorded as hypergammaglobulinemia^[6].
• DARA RVD For High Risk SMM's main subject is recorded as multiple myeloma^[7].
• DARA RVD For High Risk SMM's number of participants is recorded as {'unit': '1', 'amount': '+30'}^[8].
• DARA RVD For High Risk SMM's title is recorded as B- PRISM (Precision Intervention Smoldering Myeloma): A Phase II Trial of Combination of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in High- Risk Smoldering Multiple Myeloma^[9].
• DARA RVD For High Risk SMM's short name is recorded as PRISM^[10].
• DARA RVD For High Risk SMM's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• DARA RVD For High Risk SMM's ClinicalTrials.gov ID is recorded as NCT04775550^[12].
• DARA RVD For High Risk SMM's research intervention is recorded as immunologic factor^[13].
• DARA RVD For High Risk SMM's research intervention is recorded as angiogenesis inhibitor^[14].
• DARA RVD For High Risk SMM's research intervention is recorded as angiogenesis modulating agents^[15].
• DARA RVD For High Risk SMM's research intervention is recorded as growth inhibitors^[16].
• DARA RVD For High Risk SMM's research intervention is recorded as (RS)-cyclophosphamide^[17].
• DARA RVD For High Risk SMM's research intervention is recorded as (RS)-lenalidomide^[18].
• DARA RVD For High Risk SMM's research intervention is recorded as bortezomib^[19].
• DARA RVD For High Risk SMM's research intervention is recorded as daratumumab^[20].
• DARA RVD For High Risk SMM's research intervention is recorded as non-steroidal anti-inflammatory drug^[21].
• DARA RVD For High Risk SMM's research intervention is recorded as antiemetic^[22].
• DARA RVD For High Risk SMM's research intervention is recorded as peripheral nervous system agent^[23].
• DARA RVD For High Risk SMM's research intervention is recorded as gastrointestinal agent^[24].
• DARA RVD For High Risk SMM's research intervention is recorded as hormones, hormone substitutes, and hormone antagonists^[25].
• DARA RVD For High Risk SMM's research intervention is recorded as hormonal antineoplastic agent^[26].